Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?
Guglielmetti L, Le Dû D, Veziris N, Caumes E, Marigot-Outtandy D, Yazdanpanah Y, Robert J, Fréchet-Jachym M; MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort. Guglielmetti L, et al. Eur Respir J. 2016 Aug;48(2):582-5. doi: 10.1183/13993003.00411-2016. Epub 2016 Jun 23. Eur Respir J. 2016. PMID: 27338196 Free article. No abstract available.
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors.
Veziris N, Bernard C, Guglielmetti L, Le Du D, Marigot-Outtandy D, Jaspard M, Caumes E, Lerat I, Rioux C, Yazdanpanah Y, Tiotiu A, Lemaitre N, Brossier F, Jarlier V, Robert J, Sougakoff W, Aubry A; CNR MyRMA and the Tuberculosis Consilium of the CNR MyRMA; CNR MyRMA and Tuberculosis Consilium of the CNR MyRMA. Veziris N, et al. Among authors: marigot outtandy d. Eur Respir J. 2017 Mar 22;49(3):1601719. doi: 10.1183/13993003.01719-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28182568 Free article. No abstract available.
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis.
Guglielmetti L, Jaspard M, Le Dû D, Lachâtre M, Marigot-Outtandy D, Bernard C, Veziris N, Robert J, Yazdanpanah Y, Caumes E, Fréchet-Jachym M; French MDR-TB Management Group. Guglielmetti L, et al. Among authors: marigot outtandy d. Eur Respir J. 2017 Mar 22;49(3):1601799. doi: 10.1183/13993003.01799-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28182570 Free article.
Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia.
Guglielmetti L, Barkane L, Le Dû D, Marigot-Outtandy D, Robert J, Veziris N, Yazdanpanah Y, Kuksa L, Caumes E, Fréchet-Jachym M. Guglielmetti L, et al. Among authors: marigot outtandy d. Eur Respir J. 2018 Mar 22;51(3):1702550. doi: 10.1183/13993003.02550-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29419439 Free article. No abstract available.
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.
Guglielmetti L, Jaffré J, Bernard C, Brossier F, El Helali N, Chadelat K, Thouvenin G, Dautzenberg B, Henry B, Jaspard M, Guillot H, Pourcher V, Le Dû D, Marigot-Outtandy D, Mougari F, Raskine L, Rivoire B, Andrejak C, Jarlier V, Aubry A, Robert J, Frechet-Jachym M, Veziris N. Guglielmetti L, et al. Among authors: marigot outtandy d. Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1050-1054. doi: 10.5588/ijtld.18.0779. Int J Tuberc Lung Dis. 2019. PMID: 31627768
Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
Tunesi S, Dû DL, Gualano G, Millet JP, Skrahin A, Bothamley G, Casas X, Goletti D, Lange C, Musso M, Palmieri F, Pourcher V, Rioux C, Skrahina A, Veziris N, Viatushka D, Jachym-Fréchet M, Guglielmetti L; TBnet, The ESGMYC, and The French MDR-TB Group. Tunesi S, et al. J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.03.004. Epub 2022 Mar 7. J Infect. 2022. PMID: 35271917 No abstract available.
Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France.
Bonnet I, Haddad E, Guglielmetti L, Bémer P, Bernard L, Bourgoin A, Brault R, Catho G, Caumes E, Escaut L, Fourniols E, Fréchet-Jachym M, Gaudart A, Guillot H, Lafon-Desmurs B, Lanoix JP, Lanotte P, Lemaignen A, Lemaire B, Lemaitre N, Michau C, Morand P, Mougari F, Marigot-Outtandy D, Patrat-Delon S, Perpoint T, Piau C, Pourcher V, Zarrouk V, Zeller V, Veziris N, Jauréguiberry S, Aubry A; CRIOAC Pitié-Salpêtrière and the TB Consilium of the National Reference Center for Mycobacteria. Bonnet I, et al. Among authors: marigot outtandy d. Microorganisms. 2022 Jun 14;10(6):1215. doi: 10.3390/microorganisms10061215. Microorganisms. 2022. PMID: 35744731 Free PMC article.
Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment.
Eimer J, Fréchet-Jachym M, Le Dû D, Caumes E, El-Helali N, Marigot-Outtandy D, Mechai F, Peytavin G, Pourcher V, Rioux C, Yazdanpanah Y, Robert J, Guglielmetti L; LZDM group. Eimer J, et al. Among authors: marigot outtandy d. Clin Infect Dis. 2023 Feb 8;76(3):e947-e956. doi: 10.1093/cid/ciac485. Clin Infect Dis. 2023. PMID: 35717636
15 results